Yuu Akuzawa, Naoki Takahashi, Mika Kohri, Kunihiro Tsukasaki, Tsuyoshi Saeki, Daisuke Okamura, Maho Ishikawa, Tomoya Maeda, Akira Matsuda, Norio Asou (Hematol, Saitama medical Univ, Saitama, Japan)
Session information
Oral Session
Oral Session 2-7C PTCL/NK lymphoma: Treatment (2)
Sat. Oct 13, 2018 2:50 PM - 3:50 PM No.7 (Osaka International Convention Center, 10F 1001)
Chair: Ritsuro Suzuki (Department of Oncology Hematology,Shimane Universiy Hospital, Japan)
Takashi Ishida1,2, Kiyoshi Ando3, Makoto Yoshimitsu4, Shinichiro Yoshida5, Kensei Tobinai6, Ilseung Choi7, Michihiro Hidaka8, Yasushi Takamatsu9, Gloria Lee10, Gillings Mireille10 (1.Nagoya City University Hospital, Nagoya, Japan, 2.School of Medicine, Iwate Medical University, Morioka, Japan, 3.Tokai University Hospital, Isehara, Japan, 4.Kagoshima University Hospital, Kagoshima, Japan, 5.Nagasaki Medical Center, Ohmura, Japan, 6.National Cancer Center Hospital, Tokyo, Japan, 7.Kyushu Cancer Center, Fukuoka, Japan, 8.Kumamoto Medical Center, Kumamoto, Japan, 9.Fukuoka University Hospital, Fukuoka, Japan, 10.HUYA Bioscience International, San Diego, USA)
Akihiro Kitadate, Kota Fukumoto, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Masami Takeuchi, Kosei Matsue (Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan)
Manabu Suzuki, Saburo Tsunoda, Shohei Ikeda, Masumi Sukegawa, Masatsugu Ohta (Dep.Hematology, Fukushima Medical University, Aizu Medical Center,Fukushima,Japan)
Mai Mizusawa1, Miho Ogawa2, Kazuaki Yokoyama1, Toyotaka Kawamata1, Shohei Andoh1, Kanya Kondoh1, Tomomi Takei2, Sousuke Nakamura2, Mika Ito2, Nozomi Yusa3, Rika Kasajima4, Eigo Shimizu5, Junya Makiyama1, Hiroshi Yasui1, Rui Yamaguchi5, Seiya Imoto4, Satoru Miyano4,5, Yasunori Ota6, Noritada Yoshikawa7, Hirotoshi Tanaka7, Yoichi Imai1, Arinobu Tojo1,2 (1.Department of Hematology/Oncology, IMSUT Hospital, The University of Tokyo, 2.Division of Molecular Therapy, IMSUT, The University of Tokyo, 3.Department of Applied Genomics, IMSUT Hospital, The University of Tokyo, 4.Health Intelligence Center, IMSUT, The University of Tokyo, 5.Human Genome Center, IMSUT, The University of Tokyo, 6.Pathology and Laboratory Medicine, IMSUT Hospital, The University of Tokyo, 7.Department of Rheumatology, IMSUT Hospital, The University of Tokyo)
Ikuo Matsuda1, Satoshi Yoshihara2, Kyoko Yoshihara2, Yoshihiro Fujimori2, Seiichi Hirota1 (1.Department of Surgical Pathology, Hyogo College of Medicine, Hyogo, Japan, 2.Division of Hematology, Hyogo College of Medicine, Hyogo, Japan)